RT
A research scientist works inside a laboratory of India’s Serum Institute, the world’s largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune, India (FILE PHOTO) © REUTERS/Euan Rocha
The World Health Organization (WHO) has granted emergency use approval for the Covid-19 vaccine made by the Serum Institute of India under license from US biotech firm Novavax. The jab is the ninth to be approved by the body.
In a press release on Friday, the WHO said that the granting of emergency use listing (EUL) to the vaccine, named Covovax, was a great step forward in ongoing efforts to vaccinate more people in lower-income countries.
The shot is produced by the Serum Institute of India under license from Novavax, and the Covax vaccine-sharing initiative has already ordered some 350 million doses.
“This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10% of their populations, while 98 countries have not reached…
